202 related articles for article (PubMed ID: 36599262)
1. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
2. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
3. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
5. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
[TBL] [Abstract][Full Text] [Related]
9. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
10. A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
Pontikos N; Smyth DJ; Schuilenburg H; Howson JM; Walker NM; Burren OS; Guo H; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Jayaraman J; Jiang W; Traherne JA; Trowsdale J; Todd JA; Wallace C
BMC Genomics; 2014 Apr; 15():274. PubMed ID: 24720548
[TBL] [Abstract][Full Text] [Related]
11. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
13. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
15. Association of Killer Cell Immunoglobulin-Like Receptors and Their HLA-Ligands with Type 1 Diabetes Among South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Immunol Invest; 2023 Apr; 52(3):270-285. PubMed ID: 36705596
[TBL] [Abstract][Full Text] [Related]
16. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
Halimi H; Mirzazadeh S; Kalantar K; Hajimaghsoodi M; Ramzi M; Farjadian S
Hum Immunol; 2024 Mar; 85(2):110750. PubMed ID: 38262874
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
18. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
[TBL] [Abstract][Full Text] [Related]
19. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.
Barani S; Khademi B; Ashouri E; Ghaderi A
Hum Immunol; 2018 Apr; 79(4):218-223. PubMed ID: 29408295
[TBL] [Abstract][Full Text] [Related]
20. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
